Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress
Masanari Itokawa(Fujita Health University), Toshio Miyata(Waseda University), Takashi Dan(Tohoku University), Shinsuke Washizuka(Shinshu University), Katsuyoshi Takahashi(Tokyo Metropolitan Matsuzawa Hospital), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Taro Tokunaga(Tokyo Metropolitan Matsuzawa Hospital), Kayo Ishimoto(Tokyo Metropolitan Matsuzawa Hospital), Tomoe Ichikawa(Saitama Medical University), Takeo Yoshikawa(RIKEN Center for Brain Science), Yasue Horiuchi(National Taiwan University), Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Akiko Kobori(Tokyo Metropolitan Institute of Medical Science), Naoji Amano(Shinshu University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Yuji Okazaki(Mie University), Satoshi Usami(Japan Graduate School of Education University)
Cited by 54
Related Papers
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Protein-bound acrolein: Potential markers for oxidative stress
|Proceedings of the National Academy of Sciences|1998|631
Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications
|Kidney International|1999|516
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326